White House The White House in Washington, D.C. Source: WIkipedia https://commons.wikimedia.org/wiki/File:White_House_DC.JPG

White House Announces Updates to Modernize Biotech Regulations

The White House just announced its updates to the coordinated framework for the regulation of biotechnology products. Its ongoing process to modernize the regulatory process has been going on for the last year and has been receiving input from the industry, academia, NGO groups and members of the public.

EPA, FDA, and USDA have released two documents – a proposed Update to the Coordinated Framework for the Regulation of Biotechnology and a National Strategy for Modernizing the Regulatory System for Biotechnology Products. These documents present a comprehensive summary of the current roles and responsibilities of the three primary regulatory agencies with respect to the regulation of biotechnology products and a vision for ensuring that the Federal regulatory system is equipped to assess efficiently the risks, if any, associated with future products of biotechnology.

The new process announced articulates what regulatory parts should be taken for which product and which agencies regulate them as well as the update to the coordinated framework.

The White House also published a strategic plan outlining the various steps that will be taken in the future to ensure that the regulatory process remains updated as new biotech tools, technologies and products come online.

We’ll be discussing this important update at SynBioBeta SF 2016 on Wednesday, the 5th of October, during our regulatory panel.

John Cumbers

John Cumbers

John Cumbers is the founder of SynBioBeta. John is passionate about education and on the use and adoption of biological technologies. He has received multiple awards and grants from NASA and the National Academy of Sciences for his work in the field. John has been involved in multiple startups such as those producing food for space, microbes to extract lunar and martian resources, and hoverboards! John is an active investor through the DCVC SynBioBeta Fund and his synthetic biology syndicate on AngelList.

Stay updated on the latest news in synthetic biology

Join our weekly newsletter

Sign up

Add comment

Job opportunities

More